中图分类号:
R944
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WU B, WU L J, WANG L Q, et al. A new lactone from Senecio cannabifolius Less . J Asian Nat Prod Res, 2002, 4(4): 315-317.
[2] WU B, LIN W, GAO H Y, et al. Four new antibacterial constituents from Senecio cannabifolius . Pharm Biol, 2006, 44(6): 440-444.
[3] SUN J D, WANG X B, JIANG S, et al. Preventive effect of Senecio cannabifolius Less. Ⅱ on perfluoroisobutylene inhalation-induced acute lung injury in rats. Int J Pharm Res (国际药学研究杂志), 2014, 41(4): 444-448, 472.
[4] ZHAO G Y, WANG X B, XI R G, et al. Protective effect of Senecio cannabifolius Less. Ⅱ on acute lung injury induced by perfluoroisobutylene on mice. Pharm J Chin PLA (解放军药学学报), 2013, 29(1): 13-16, 65.
[5] ZHOU J Y, ZHANG L, MAO S R. Recent progress of dry powder inhalation of proteins and peptides . Acta Pharm Sin (药学学报), 2015, 50(7): 814-823.
[6] KAIALY W, HUSSAIN T, ALHALAWEH A, et al. Towards a more desirable dry powder inhaler formulation:large spray-dried mannitol microspheres outperform small microspheres . Pharm Res, 2014, 31(1):60-76.
[7] MURALIDHARAN P, HAYES J, DON, et al. Dry powder inhalers in COPD, lung inflammation and pulmonary infections . Expert Opin Drug Deliv, 2015, 12(6):947-962.
[8] DEMOLY P, HAGEDOOMRN P, DE B A, et al. The clinical relevance of dry powder inhaler performance for drug delivery . Respir Med, 2014, 108(8):1195-1203.
[9] LI X J, VOGT F, HAYES D, et al. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers . J Pharm Sci, 2014, 103(9):2937-2949.
YANG Y, YANG Z W, REN Y F, et al. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance . Drug Deliv, 2014, 21(6):480-486.
YOU Y, ZHAO C H, ZHAO M, et al. Preparation and deposition properties of insulin dry powder inhalation. J Shenyang Pharm Univ(沈阳药科大学学报), 2008, 25(4):243-248.
LI L, CHENG H Y, ZHU Y Y, et al. Optimal extraction of Zhizi Baipi Decoction by multi-index comprehensive scoring . Chin Tradit Pat Med (中成药), 2015, 37(2):306-310.
LI N, TANG D D, WANG L W, et al. Preparation of dry powder inhalation based on phytosomes-chitosan microspheres by spray-drying method and study on its characterization . Chin Tradit Herb Drugs (中草药), 2014, 45(17): 2475-2481.
MILLER D P, TAN T, TARARA T E, et al. Physical characterization of tobramycin inhalation powder: I. rational design of a stable engineered-particle formulation for delivery to the lungs . Mol Pharm, 2015, 12(8):2582-2593.
ATKINS P J. Dry powder inhalers: an overview . Resp Care, 2005, 50(10):1304-1312.
TULBAH A S, ONG H X, MORGAN L, et al. Dry powder formulation of simvastatin . Expert Opin Drug Deliv, 2015, 12(6):857-868.
TANG Y, ZHANG H Y, LU X F, et al. Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation . Drug Deliv, 2015, 22(5):608-618.
ZHOU Q, QU L, GENGENBACH T, et al. Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers . AAPS Pharm Sci Tech, 2013,14(1):38-44.
TULI R A, GEORGE G A, DARGAVILLE T R, et al. Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations . Pharm Res, 2012, 29(9):2445-2455.
LIANG H, SHINOHARA K, MINOSHIMA H, et al. Analysis of constant rate period of spray drying slurry . Chem Eng Sci, 2001, 56(6):2205-2213.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}